12.13GBp0.00%Mkt Cap: 50.01M GBpP/E: —Last update: 2026-05-13
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energ…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-6.65
PEG—
P/B1.93
P/S215.40
EV/EBITDA0.22
EV/Revenue-9.82
EPS (TTM)0.00
EPS (Forward)-0.02
Cash Flow & Leverage
FCF Yield-13.76%
FCF Margin-3059.28%
Operating CF-22.20M GBp
CapEx (TTM)400.00K GBp
Net Debt/EBITDA1.63
Net Debt-16.30M GBp
Technical
SMA 5012.27 (-1.2%)
SMA 20012.27 (-1.2%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)739.91K
Avg Vol (10d)479.47K
Technical Indicators
RSI (14)46.8
MACD-0.0459
MACD Signal-0.0334
MACD Hist.-0.0124
BB Upper13.29 GBp
BB Middle12.46 GBp
BB Lower11.63 GBp
BB Width13.31%
ATR (14)0.8952 GBp
Vol Ratio (20d)0.42x
52W Range
9.52029% of range18.50
52W High18.50 GBp
52W Low9.520 GBp
Profitability
Gross Margin47.50%
EBITDA Margin0.00%
Profit Margin-717.50%
Oper. Margin-454.54%
ROE-67.69%
ROA-44.15%
Revenue Growth37.50%
Earnings Growth—
Balance Sheet
Debt/Equity0.10
Current Ratio4.65
Quick Ratio4.61
Book Value/Sh0.0610 GBp
Cash/Share0.1710 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.412.47M
Float85.07M
Insiders7.82%
Institutions49.33%
Analyst Consensus
Rating—
Target (Mean)50.00 GBp
Target Range40.00 GBp – 70.00 GBp
# Analysts3
Company
Market Cap50.01M GBp
Enterprise Value-2.21M GBp
Revenue (TTM)225.00K GBp
Gross Profit1.90M GBp
Net Income (TTM)-28.70M GBp
Revenue/Share0.0030 GBp
Fiscal Year EndJun 2018
MR QuarterJun 2025
Employees—
Last Price12.13 GBp
CountryGB
SectorHealthcare
IndustryMedical Devices
ISIN—